UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE and WRONG TECHNIQUE IN DEVICE USAGE PROCESS

Overview

WRONG TECHNIQUE IN DEVICE USAGE PROCESS is the #3 most commonly reported adverse reaction for UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, manufactured by GlaxoSmithKline LLC. There are 1,571 FDA adverse event reports linking UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE to WRONG TECHNIQUE IN DEVICE USAGE PROCESS. This represents approximately 5.2% of all 30,147 adverse event reports for this drug.

Patients taking UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE who experience wrong technique in device usage process should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

WRONG TECHNIQUE IN DEVICE USAGE PROCESS is moderately reported among UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE users, representing a notable but not dominant share of adverse events.

Other Side Effects of UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

In addition to wrong technique in device usage process, the following adverse reactions have been reported for UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE:

• DYSPNOEA — 2,306 reports
• DRUG INEFFECTIVE — 1,589 reports
• PRODUCT COMPLAINT — 1,130 reports
• COUGH — 1,073 reports
• PRODUCT DOSE OMISSION ISSUE — 835 reports
• PNEUMONIA — 651 reports
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE — 607 reports
• CONDITION AGGRAVATED — 498 reports
• DRUG DISPENSING ERROR — 496 reports
• DRUG DOSE OMISSION — 472 reports

Other Drugs Associated with WRONG TECHNIQUE IN DEVICE USAGE PROCESS

The following drugs have also been linked to wrong technique in device usage process in FDA adverse event reports:

Does UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE cause WRONG TECHNIQUE IN DEVICE USAGE PROCESS?

WRONG TECHNIQUE IN DEVICE USAGE PROCESS has been reported as an adverse event in 1,571 FDA reports for UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is WRONG TECHNIQUE IN DEVICE USAGE PROCESS with UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE?

WRONG TECHNIQUE IN DEVICE USAGE PROCESS accounts for approximately 5.2% of all adverse event reports for UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, making it one of the most commonly reported side effect.

What should I do if I experience WRONG TECHNIQUE IN DEVICE USAGE PROCESS while taking UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE?

If you experience wrong technique in device usage process while taking UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages